LUMBY, British Columbia, March 26, 2009 (GLOBE NEWSWIRE) -- avVaa World Health Care Products, Inc. (Pink Sheets:AVVH) is a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products. avVaa's patented mineral topical solutions are formulated to treat and relieve the adverse effects of chronic skin conditions/irritations, by improving the quality of life and well-being of our consumers, both human and animal.
The avVaa founders Jack Farley and Lorie Campbell-Farley are in final stages of negotiations with direct response TV, a multimedia Production company that specializes in 120, 60, 30, 10 second short version infomercials dedicated to launching avVaa's core products. Their direct response team is responsible for generating over 400 million dollars in direct response television sales. The objective in the first 12-month period is to complete up to three 120-second commercials in an infomercial format, with the objective to produce an infomercial intended to generate product sales, while at the same time increasing public awareness of the products. In addition, the program will concurrently act as a lead generation tool for follow-up sales, as well as creating brand awareness to help generate new retail opportunities.
Projections for the launching of the first 120-second Neuroskin(r) infomercial with Neuroskin(r) Psoriasis Relief and the Neuroskin(r) Scalp Shampoo Moisturizer, with an expected 1.8 media efficiency ratio show gross sales from this program in the first 6 months after the initial rollout program of $8,900,000. The investment of $55,000 completes all stages of the first 120 second infomercial. The expected success of our infomercial will make Neuroskin(r) a household name. The extended results for a 12-month period of this TV branding forecast a projected gross retail sales profitability of $ 2,800,000.00. Dr. Mark Alden and Dr. Zamora along with founder Jack Farley will be part of the infomercial along with testimonials from individuals who have suffered from Psoriasis. avVaa has built up enough inventory at the Chicago Manufacturing facility to fill all orders during the infomercial test months plus several months into the full roll-out of the program.
avVaa's 2nd infomercial is scheduled for dermalustre(r), the all natural treatment with no harmful chemicals. Both Equine and Pet Industry professionals recommend dermalustre(r) as an excellent conditioner, repairing dry brittle coats, manes and tails, and relieving dry, itchy and flaky skin. dermalustre(r) is a one-step professional skin and coat treatment product with added benefits of a grooming spray that produces a bright healthy shine to the coat.
Projections for the launching of the dermalustre(r) infomercial with an expected 1.8 media efficiency ratio show gross sales from this program in the first 6 months of $6,256,000 with an investment of $55,000 to create the 120 second infomercial. The expected success of our infomercial with direct response TV will make dermalustre(r) a household name. Dr. Carol, avVaa's spokesperson for animal care along with founder Lorie Campbell-Farley will be in the infomercial along with satisfied users of dermalustre(r). avVaa World Health Care is proud to announce that we have in excess of $670,000.00 in dermalustre product ready for the infomercial test months.
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers.
avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne.
avVaa is poised to manufacture and market its OTC Neuroskin(r) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada.
Safe Harbor:
Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward- looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.